Transcutaneous Jaundice Tester RB321
$492.00~632.00 / Parcel Min.order:20

About this item:

Transcutaneous Jaundice Tester (RB321) is a hand-held instrument for clinical dynamic monitoring of neonatal jaundice. The instrument quickly and painlessly measured the percutaneous bilirubin value related to the serum bilirubin concentration through the skin appearance of the newborn, eliminating the pain caused by blood collection and measurement to the newborn, and also convenient for medical staff.

18cm * 6cm * 3.5cm

0.16kg

Support Payment Term:

HSBC Hong Kong

paypal

Alibaba Pay

Western Union

USD

EUR

GBP

SGD

HKD

CNH

CAD

MXN

BRL

JPY

THB

MOP

AUD

NZD

PLN

CZK

HUF

RON

CHF

SEK

NOK

DKK

TRY

AED

SAR

ILS

ZAR

$0.00

Quantity

Discover similar items

Page 1 of 2

Transcutaneous Jaundice Tester(RB321), which is independently developed and produced by our company, uses the light wave difference between blue light wave (450mm) and green light wave (550nm) to determine the concentration of bilirubin precipitate in the skin tissue of newborn infants. Transcutaneous Jaundice Tester probe has two light waves, which can be used to determine the minimum bilirubin concentration in newborn skin tissue under the influence of melanin and skin maturity. This point is not achieved by traditional means.

Transcutaneous Jaundice Tester(RB321) is a hand-held instrument for clinical dynamic monitoring of neonatal jaundice. The instrument quickly and painlessly measured the percutaneous bilirubin value related to the serum bilirubin concentration through the skin appearance of the newborn, eliminating the pain caused by blood collection and measurement to the newborn, and also convenient for medical staff. Combining electronic technology, optical technology and information processing technology, the instrument has the characteristics of accurate measurement, fast and safe detection, small size, light weight, long service life, low energy consumption, easy use and maintenance, and is widely used in neonatology departments and child care departments at all levels of hospitals for early screening of neonatal jaundice, and has broad market application prospects.